Search clinical trials for: TENEO

Total 9 results

TeneoOne Inc.

Recruiting

A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

Israel, United States, Canada, Spain, France, Denmark, United Kingdom
Bausch & Lomb Incorporated

Recruiting

Safety and Effectiveness of the TENEO 317 Model 2 (1.28 US) Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Hyperopia With or Without Astigmatism

Hyperopia

United States
TeneoOne Inc.

Recruiting

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-383 in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Multiple Myeloma

Australia, Germany, Japan, Spain, United States, Italy, Poland
TeneoFour Inc.
Novotech (Australia) Pty Limited

Completed

A Single and Multiple Dosing Study Targeting Biparatopic Antibody CD38 in Healthy Volunteers

Healthy Volunteer

Australia
TeneoOne Inc.
AbbVie

Active, not recruiting

A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States, Germany
Bausch & Lomb Incorporated

Completed

A Study With Technolas® TENEO 317 Model 2 Excimer Laser to Treat Participants With Myopia or Myopic Astigmatism

Myopia | Myopic Astigmatism

United States
TeneoOne Inc.

No longer available

Expanded Access for TNB-383B in a Subject With Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

United States
Technolas Perfect Vision GmbH

Unknown

A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser Using LASIK

Myopia | Hyperopia

China
Centre Jean Perrin
Sanofi; Merck Sharp & Dohme LLC

Completed

Assessment of the Efficacy of a Neoadjuvant Combination: "Chemotherapy-targeted Therapy" in Breast Cancer.

Breast Cancer

France

3

Subscribe